patients treated with the nsb drug capsules along with the “standard of care treatment” (arm b) exhibited 100% clinical benefits when compared to patients in the treatment arm a, thus indicating the tremendous clinical benefits of nsb drug in adjuvant therapy. the secondary objective was to determine the efficacy of nsb drug (trade name: dnanostanna) in terms of response rate in participating breast cancer patients assessed by radiographic evaluation by recist criteria. thirty milligrams of the dry mango peel powder was added to 6 ml of di water in a 20 ml vial and stirred for 10 min at rt for the complete homogenous suspension. animals were sacrificed at the end of the study. as per plan, a total of six patients enrolled in the study were randomized to either of the two treatment arms: treatment a and treatment b in 1:1 ratio. in the arm b, patients were instructed to take two nsb drug capsules thrice a day after food with sufficient quantity of water by themselves at home. comparison between the groups was performed for standard of care treatment alone and standard of care treatment with nsb drug.
the nsb drug was characterized by tem technique for qualitative analysis of aunps in the drug formulation. in order to test the in vitro antitumor efficacy of the nsb drug, serial dilutions were prepared in dmem (dulbecco’s modified eagle medium) media for treatment with tumor cells. the in vivo study was performed over a period of 8–9 weeks; the day of randomization and treatment was considered as day zero. efficacy was a secondary objective of the study. more than 50% of total reported aes were from treatment arm a, out of which 05 were possibly related and one each was unlikely related and unrelated to the study drug. out of the remaining six patients, three patients were treated with treatment a and three were treated with treatment b. all six patients completed the study and received full dose of treatment in both groups a and b as per randomization. this study was conducted in accordance with the ethical principles laid down by declaration of helsinki (taipei 2016) following the principles of ich guidelines for good clinical practice (1997) and schedule. the authors report no other conflicts of interest in this work.
the .gov means it’s official. the site is secure. purpose: the overarching objective of this investigation was to investigate the intervention of green nanotechnology to transform the ancient holistic ayurvedic medicine scientifically credible through reproducible formulations and rigorous pre-clinical/clinical evaluations.
results: the preclinical in vitro and in vivo investigations, in breast tumor bearing mice, established unequivocally that the nsb nano-ayurvedic medicine-gold nanoparticles-based drug is highly effective in controlling the growth of breast tumors in a dose dependent fashion in vivo. these encouraging pre-clinical results prompted us to seek permission from the indian government’s holistic medicine approval authority, ayush, for conducting clinical trials in human patients. conclusion: we have succeeded in clinically translating, from mice to humans, in using proprietary combinations of gold nanoparticles and phytochemicals to develop the nano-ayurvedic drug: nano swarna bhasma (nsb), through innovative green nanotechnology, for treating human metastatic breast cancer patients. the authors report no other conflicts of interest in this work.
the preclinical in vitro and in vivo investigations, in breast tumor bearing mice, established unequivocally that the nsb nano-ayurvedic results: the preclinical in vitro and in vivo investigations, in breast tumor bearing mice, established unequivocally that the nsb nano- certain ayurvedic herbs like bitter melon or green tea, symptoms of breast cancer, symptoms of breast cancer.
it is a compound from the ayurvedic medicinal plant withania somnifera. they found that withaferin a stopped the growth of some types of breast cancer cells in test tubes. it also stopped the growth of breast cancer in mice. several other studies support these findings. breast cancer patients popularly use black cohosh or actaea racemosa plant to treat hot flushes, which gives conflicting but promising results. our special medicine sj – 29 drop concentrate is administered. it destroys the cancer cells and prevents their growth. it selectively kills the diseased cells. ayurvedic treatment is patient-tailored and consists of oral formulations containing herbal, mineral, spice, and animal components;, .
When you try to get related information on ayurvedic breast cancer treatment, you may look for related areas. symptoms of breast cancer.